A proposed model for HA-CD44-mediated PKCE activation and Nanog signaling in the regulation of miRNA-21 production, oncogenesis, and chemoresistance in breast tumor cells
A proposed model for HA-CD44-mediated PKCϵ activation and Nanog signaling in the regulation of miRNA-21 production, oncogenesis, and chemoresistance in breast tumor cells. The binding of HA to CD44 (step 1) promotes PKCϵ activity (step 2), which, in turn, causes phosphorylation of Nanog (step 3). Phosphorylated Nanog then translocates from the cytosol to the nucleus and interacts with the microprocessor complex containing the RNase III (DROSHA) and the RNA helicase (p68) (step 4), resulting in miR-21 production (step 5). The resultant miR-21 then functions to down-regulate the tumor suppressor protein (PDCD4) (step 6a; indicated by the arrow with solid lines) and promotes oncogenesis (step 7a; indicated by the arrow with solid lines), leading to IAP (survivin and XIAP)/MDR1 (P-gp) expression, breast tumor cell anti-apoptosis/survival, and chemoresistance (step 8a; indicated by the arrow with solid lines). In direct contrast, treatment of breast tumor cells with an anti-miR-21 inhibitor (indicated by the arrow with dashed lines) induces tumor suppressor protein (PDCD4) up-regulation and PDCD4-eIF4A complex formation, which then inhibits translational machinery (step 6b; indicated by the arrow with dashed lines). Subsequently, these changes result in the inhibition of IAP (survivin and XIAP) and MDR1 expression (step 7b; indicated by the arrow with dashed lines), stimulation of apoptosis/cell death, and enhancement of chemosensitivity (step 8b; indicated by the arrow with dashed lines) in breast tumor cells. This newly discovered PKCϵ-Nanog signaling pathway leading to miR-21 functioning should provide important drug targets for sensitizing tumor cell apoptosis and overcoming chemoresistance in HA-CD44-activated breast cancer cells.
Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells. (2009)
Lilly Y. W. Bourguignon, et al. J Biol Chem. 2009 Sep 25;284(39):26533-26546. Figure: F8.